During the recent STAT @ ASH event in San Diego, panelists explored the role of community oncology in advancing precision medicine for cancer care.
Uniquely positioned
to advance cancer care
Unparalleled Oncology Platform
McKesson’s portfolio of businesses helps create a real difference for patients living with cancer.
Supporting Every Aspect of Cancer Care
Together with the largest network of independent community oncologists, we power cancer innovation, value-based care, and better patient outcomes. Our unmatched portfolio of oncology businesses delivers research, insights, technologies and solutions that help drive cancer care forward.
We accelerate oncology innovation to help providers, biopharma companies and payers strengthen their businesses and deepen patient connections.
*Learn more about McKesson and HCA Healthcare’s plans to form an oncology research joint venture.
We work with biopharma companies, care providers, pharmacies and others to make cancer care more accessible and affordable.
Through our legacy expertise in supply chain solutions and our patient-first approach, we help ensure therapies are available, accessible and affordable.
Learn about McKesson’s new Cell and Gene Therapy (CGT) brand, InspiroGene, and the launch of a first-of-its-kind report about the CGT landscape and its future trajectory.
Leading experts from an Endpoints News panel share actions that can be taken to foster equitable access and improve outcomes for cancer patients.
top